People: Neuralstem Inc (CUR)
CUR on American Stock Exchange
1.49USD
17 May 2013
1.49USD
17 May 2013
Price Change (% chg)
$0.04 (+2.76%)
$0.04 (+2.76%)
Prev Close
$1.45
$1.45
Open
$1.52
$1.52
Day's High
$1.59
$1.59
Day's Low
$1.40
$1.40
Volume
2,133,474
2,133,474
Avg. Vol
412,325
412,325
52-wk High
$1.96
$1.96
52-wk Low
$0.42
$0.42
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Karl Johe |
52 | 1996 | Chairman of the Board, Chief Scientific Officer |
I. Richard Garr |
60 | 2012 | President, Chief Executive Officer, Interim Chief Financial Officer, General Counsel, Director |
Scott Ogilvie |
58 | 2008 | Independent Director |
William Oldaker |
71 | 2007 | Independent Director |
Stanley Westreich |
75 | 2011 | Independent Director |
David Castaneda |
IR Contact |
Biographies
| Name | Description |
|---|---|
Karl Johe |
Dr. Karl Johe, Ph.D., is Chairman of the Board and Chief Scientific Officer of Neuralstem, Inc., since 1996. Dr. Johe has over 15 years of research and laboratory experience. Dr. Johe is the sole inventor of Neuralstem’s granted stem cell patents and is responsible for the strategic planning and development of therapeutic products. Dr. Johe received his Bachelor of Arts Degree in Chemistry and a Master’s Degree from the University of Kansas. Dr. Johe received his doctorate from the Albert Einstein College of Medicine of Yeshiva University. From 1993 to January 1997, Dr. Johe served as a Staff Scientist at the Laboratory of Molecular Biology of the National Institute of Neurological Disease and Stroke in Bethesda, Maryland. While holding this position, Dr. Johe conducted research on the isolation of neural stem cells, the elucidation of mechanisms directing cell type specification of central nervous system stem cells and the establishment of an in vitro model of mammalian neurogenesis. |
I. Richard Garr |
Mr. I. Richard Garr, J.D., is President, Chief Executive Officer, Interim Chief Financial Officer, General Counsel, Director of Neuralstem, Inc. Mr. Garr was previously an attorney with Beli, Weil & Jacobs, the B&G Companies, and Circle Management Companies. Mr. Garr is a graduate of Drew University (1976) and the Columbus School of Law, The Catholic University of America (1979). Additionally, he was a founder and current Board member of the First Star Foundation, a children’s charity focused on abused children’s issues; a founder of The Starlight Foundation Mid Atlantic chapter, which focuses on helping seriously ill children; and is a past Honorary Chairman of the Brain Tumor Society. |
Scott Ogilvie |
Mr. Scott V. Ogilvie is Independent Director of Neuralstem, Inc., since February 2008. Mr. Ogilvie is currently the President of AFIN International, Inc., a private equity/business advisory firm, which he founded in 2006. Additionally, Mr. Ogilvie has served as a partner of Wirthlin Worldwide International, a private strategic advisory and M&A firm, since September 2011. Prior to December 31, 2009, he was CEO of Gulf Enterprises International, Ltd, a company that brings strategic partners and investment capital to the Middle East and North Africa. He held this position since August 2006. Mr. Ogilvie previously served as Chief Operating Officer of CIC Group, Inc., an investment manager, a position he held from 2001 to 2007. He began his career as a corporate and securities lawyer with Hill, Farrer & Burrill, and has public and private corporate management and board experience in finance, real estate, and technology companies. During the past 5 years, Mr. Ogilvie has served on the board of directors of Neuralstem, Inc. (NYSE AMEX:CUR), Innovative Card Technologies, Inc. (OTCBB:INVC) and Preferred Voice Inc, (OTCBD:PRFV) and GenSpera, Inc. (OTCBB: GNSZ). |
William Oldaker |
Mr. William Oldaker is Independent Director of Neuralstem, Inc., since April 12, 2007. Mr. Oldaker is a founder and partner in the Washington, D.C. law firm of Oldaker Group LLC. Prior to founding the firm in 1993, Mr. Oldaker was a partner in the Washington office of the law firm of Manatt, Phelps and Phillips from 1987 to 1993. In 2004, Mr. Oldaker was a founder of Washington First Bank in Washington, D.C. and serves as a member of the board of directors. He previously served as a director of Century National Bank, from 1982 until its acquisition in 2001. Mr. Oldaker was appointed by President Clinton to serve as a commissioner on the National Bioethics Advisory Commission, a post he held until 2001. He is a member of the Colorado, D.C. and Iowa Bar Associations, the Bar Association for the Court of Appeals, D.C., and the Bar of the United States Supreme Court. He is also a partner in The National Group, a consulting firm. He also was a founding member, and has served on the board of directors of a bank for almost thirty years. |
Stanley Westreich |
Mr. Stanley I. Westreich is Independent Director of Neuralstem Inc., since February 15, 2011. Mr. Westreich is the manager of Westreich Services, LLC, a private investment and advisory firm which he founded in 2005. Prior to founding Westreich Services, LLC, Mr. Westreich was President of Westfield Realty, Inc., a real estate development and construction company, from 1965 to 2005. From July 26, 1994 to May 2010 he served as a director of Capital One Financial Corporation and also served as a director of Capital One Bank (USA), National Association. He served as a member of the Capital One Financial Corporation Compensation Committee from March 1995 through February 2010 and was its Chairman from March 1995 through April 2005. He has also served on the Capital One Financial Corporation Finance and Trust Oversight Committee from April 2004 to May of 2010. e holds a Juris Doctorate from New York University and a Bachelors of Business Administration from The University of Miami. |
David Castaneda |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Karl Johe |
1,103,460 |
I. Richard Garr |
999,080 |
Scott Ogilvie |
-- |
William Oldaker |
-- |
Stanley Westreich |
-- |
David Castaneda |
-- |
As Of 30 Dec 2011
Options Compensation
| Name | Options | Value |
|---|---|---|
Karl Johe |
0 | 0 |
I. Richard Garr |
0 | 0 |
Scott Ogilvie |
0 | 0 |
William Oldaker |
0 | 0 |
Stanley Westreich |
0 | 0 |
David Castaneda |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
JOHE KARL |
12,800 | $1.13 |
JOHE KARL |
12,800 | $1.14 |
GARR I RICHARD |
12,000 | $1.15 |
JOHE KARL |
12,800 | $1.18 |
JOHE KARL |
12,800 | $1.27 |
JOHE KARL |
12,800 | $1.16 |
JOHE KARL |
12,800 | $1.00 |
GARR I RICHARD |
3,000 | $0.00 |
GARR I RICHARD |
120,821 | $0.00 |
GARR I RICHARD |
14,000 | $0.00 |
GARR I RICHARD |
14,000 | $0.00 |
JOHE KARL |
256,790 | $0.00 |
JOHE KARL |
745,000 | $0.00 |

